The Michael Smith Laboratories is pleased to highlight one of our outstanding graduate students, Heather…
karnottJanuary 29, 2024
Bold Therapeutics, a clinical-stage biopharmaceutical company developing novel metallotherapeutics, presented positive Phase 2 safety and…
karnottJanuary 26, 2024
STEMCELL Technologies, Canada’s largest biotechnology company, is pleased to announce the acquisition of Propagenix Inc.—a…
karnottJanuary 26, 2024
Nephritis is a common manifestation of IgA vasculitis and is morphologically indistinguishable from IgA nephropathy.…
karnottJanuary 25, 2024
Endometriosis affects nearly 1 in 10 women in Canada and an unmeasured number of gender…
karnottJanuary 25, 2024
Six UBC faculty of medicine community members have been honoured by the Canadian Association for…
karnottJanuary 25, 2024
Hepatocellular carcinoma (HCC) is widely known to be chemo-resistant and presents with significant liver disease…
karnottJanuary 24, 2024
To date, four COVID-19 vaccines have been approved for use in Canada and priority populations…
pthomsonMarch 16, 2021
Researchers have discovered a new targeted therapy that could have long-lasting effectiveness and few side…
pthomsonMarch 16, 2021
The need for new therapies and state-of-the-art care for Canadians with Alzheimer’s disease has motivated…
pthomsonMarch 15, 2021
AbCellera (Nasdaq: ABCL) today announced that bamlanivimab (LY-CoV555) 700 mg, a human antibody discovered by…
pthomsonMarch 15, 2021
Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical stage biopharmaceutical company, today announced the pricing of its underwritten…
sciencecityMarch 12, 2021
The social media app TikTok isn't all viral pranks and teen drama. A B.C.-based instructor…
pthomsonMarch 12, 2021
Dr. Timothy O’Connor has returned as Director of the Graduate Program in Neuroscience, a role he previously held…
sciencecityMarch 11, 2021
Genome BC has established a leading role in scientific research in the country and has…
sciencecityMarch 10, 2021
